Food preferences in Prader-Willi syndrome, normal weight and obese controls

International Journal of Obesity

Volumn 21, Issue 11, 1997, Pages 1046-1052

  Fieldstone, A ^a   Zipf, W B ^b   Schwartz, H C ^a   Berntson, G G ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Carbohydrate; Fat; Food preference; Hypothalamus; Obesity; Prader Willi syndrome; Protein

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; FAT INTAKE; FEMALE; FOOD PREFERENCE; HUMAN; MALE; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN INTAKE;

EID: 0030729866     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800514     Document Type: Article

References (49)

1. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: the national health and nutrition examination surveys, 1960-1961. JAMA 1994; 272: 205-239.
2. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study of 1922-1935. N Eng J Med 1992; 327: 1350-1355.
3. Adams-Campbell LL, Peniston RL, Kim KS, Mensah E. Body mass index and coronary artery disease in African-Americans. Obes Res 1995; 3: 215-219.
4. Horswill CA, Zipf WB. Elevated blood pressure in obese children: influence of gender, age, weight and serum insulin levels. Int J Obes 1991; 15: 453-459.
5. Merlino G, Scaglione R, Corrao S, D'Amico C, Paterna S, Licata A, Parrinello G, Ganguzza A, Licata G. Association between reduced lymphocyte β-adrenergic receptors and left ventricular dysfunction in young obese subjects. Int J Obes 1994; 18: 699-703.
6. Valensi P, Phan Thi BN, Lormeau B, Paries J, Attali JR. Cardiac autonomie function in obese patients. Int J Obes 1995; 19: 113-118.
7. Astrup A, Buemann B, Western P, Toubro S, Raben A, Christensen NJ. Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutr 1994; 59: 350-355.
8. Leibowitz SF. Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. TINS 1992; 15: 491-497.
9. Blundell JE, Burley VJ, Cotton JR, Lawton CL. Dietary fat and the control of energy intake: evaluating the effects of fat on meal size and postmeal satiety. Am J Clin Nutr 1993; 57(suppl): 772S-778S.
10. Lawton CL, Burley VJ, Wales JK, Blundell JE. Dietary fat and appetite control in obese subjects: weak effects on satiation and satiety. Int J Obes 1993; 17: 409-416.
11. Rolls BJ, Kim-Harris S, Fischman MW, Foltin RW, Moran TH, Stoner SA. Satiety after preloads with different amounts of fat and carbohydrate: implications for obesity. Am J Clin Nutr 1994; 60: 476-487.
12. Warwick ZS. Probing the causes of high-fat diet hyperphagia: a mechanistic and behavioral dissection. Neurosci Biobehav Rev 1996; 20: 155-161.
13. Rolland-Cachera MF, Deheeger M, Akrout M, Bellisle F. Influence of macronutrients on adiposity development: a follow up study of nutrition and growth from 10 months to eight years of age. Int J Obes 1995; 19: 573-578.
14. Butler MG, Meaney FJ, Palmer CG. Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome. Am J Med Gen 1986; 23: 793-809.
15. Dittrich B, Robinson WP, Knoblauch H, Buiting K, Schmidt K, Gillessen-Kaesbach G, Horsthemke B. Molecular diagnosis of the Prader-Willi and Angelman syndromes of detection of parent-of-origin specific DNA methylation in 15q11-13. Hum Gen 1992; 90: 313-315.
16. Knoll JHM, Nicholls RD, Magenis JM, Graham Jr JM, Lalande M, Latt SA. Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Gen 1989; 32: 285-290.
17. Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan BS, Crawford JD. Deletion of chromosome 15 as a cause of the Prader-Willi syndrome. N Eng J Med 1981; 304: 325-329.
18. Magenis RE, Toth-Fegel S, Allen LJ, Black M, Brown MG, Budden S, Cohen R. Comparison of the 15q deletions in Prader-Willi and Angelman syndromes: specific regions, extent of deletions, parental origin, and clinical consequences. Am J Med Gen 1990; 35: 333-349.
19. Nicholls RD, Knoll JHM, Butler MG, Karam S, Lalande M. Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi syndrome. Nature 1989; 342: 281-285.
20. Ozcelik T, Leff S, Robinson W, Donlon T, Lalande M, Sanjines E, Schinzel A, Francke U. Small nuclear ribonucleo-protein polypeptide N(SNRPN), an expressed gene in the Prader-Willi syndrome critical region. Nat Gen 1992; 2: 265-269.
21. Reis A, Dittrich B, Greger V, Buiting K, Lalande M, Gillessen-Kaesbach G, Anvret M, Horsthemke B. Imprinting mutations suggested by abnormal DNA methylation patterns in familial Angelman and Prader-Willi syndromes. Am J Hum Gen 1994; 54: 741-747.
22. Robinson WP, Bottani A, Yagang X, Balakrishnan J, Binhert F, Machler M, Prader A, Schinzel A. Clinical, molecular, and cytogenetic survey of potential Prader-Willi syndrome patients. In: Cassidy SB (ed), Prader-Willi Syndrome and Other Chromosome 15q Deletion Disorders. Springer-Verlag: Berlin, New York, 1992, pp 53-58.
23. A receptor β3 subunit to the Angelman/Prader-Willi region of human chromosome 15. Am J Hum Gen 1991; 49: 330-337.
24. Wenger SL, Hanchett JM, Steele MW, Maier BV, Golden WL. Clinical comparison of 59 Prader-Willi patients with and without the 15(q12) deletion. Am J Med Gen 1987; 28: 881-887.
25. Cassidy SB. Prader-Willi syndrome: overview and genetics. Symposium conducted at the Prader-Willi syndrome Conference for Professionals and Families, May 1995, Columbus.
26. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F. Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics 1993; 91: 398-402.
27. Prader A, Labhart A, Willi H. Ein syndrom von adipositas, kleinwucs, kryptorchismus und oligophrenie nach myatonicartigem zustand im neugeborenalter. Schweiz Med Wochenschr 1956; 86: 1260-1261.
28. Bray GA, Dahms WT, Swerdloff RS, Fisher RH, Atkinson RL, Carrel RE. The Prader-Willi syndrome: A case study of 40 patients and a review of the literature. Medicine 1983; 62: 59-80.
29. Cassidy SB. Prader-Willi syndrome. Cur Prob Ped 1984; 14: 1-55.
30. Holm VA, Pipes PL. Food and children with Prader-Willi syndrome. Am J Dis Child 1976; 130: 1063-1067.
31. Wenger SL, Hanchett JM, Steele MW, Maier BV, Golden WL. Clinical comparison of 59 Prader-Willi patients with and without the 15(q12) deletion. Am J Med Gen 1987; 28: 881-887.
32. Taylor RL, Caldwell ML. Type and strength of food preferences of individuals with Prader-Willi syndrome. J Ment Defic Res 1985; 29: 109-112.
33. Leibowitz SF. Brain monoamines and peptides: role in the control of eating behavior. Fed Proc 1986; 45: 1396-1403.
34. Leibowitz SF. Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. TINS 1992; 15: 491-497.
35. Leibowitz SF, Weiss GF, Yee F, Tretter JB. Noradrenergic innervation of the paraventricular nucleus: Specific role in control of carbohydrate ingestion. Brain Res Bull 1985; 14: 561-567.
36. Caldwell ML, Taylor RL, Bloom SR. An investigation of the use of high- and low-preference food as a reinforcer for increased activity of individuals with Prader-Willi syndrome. J Ment Defic Res 1986; 30: 347-354.
37. Sclafani A. Carbohydrate taste, appetite and obesity: an overview. Neurosci Biobehav Rev 1987; 11: 131-153.
38. Wurtman JJ. Abnormal regulation of carbohydrate consumption. In: Carruba MO, Blundell JE (eds), Pharmacology of eating disorders: theoretical and clinical developments. Raven Press: New York, 1986, pp 133-139.
39. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 1996; 20: 1-25.
40. Vaccarino FJ, Bloom FE, Rivier J, Vale W, Koob GF. Nature 1985; 314: 167-168.
41. Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrin Metab 1995; 80: 573-579.
42. Leibowitz SF. Brain Neuropeptide Y: An integrator of endocrine, metabolic and behavioral processes. Brain Res Bull 1991; 27: 333-337.
43. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 1992; 12: 1040-1062.
44. Cooper SJ, Barber DJ, Gilbert DB, Moores WR. Benzodiazepine receptor ligands and the consumption of a highly palatable diet in non-deprived male rats. Psychopharmacology 1985; 86: 348-355.
45. Berridge KC, Pecina S. Benzodiazepines, appetite and taste palatability. Neurosci Biobehav Rev 1995; 19: 121-131.
46. Drewnowski A, Brunzell JD, Sande K, Iverius PH, Greenwood MRC. Sweet tooth reconsidered: taste responsiveness in human obesity. Physiol Behav 1985; 35: 617-622.
47. Drewnowski A, Kurth C, Holden-Wiltse J, Saari J. Food preferences in human obesity: carbohydrates versus fats. Appetite 1992; 18: 207-221.
48. Drewnowski A, Pierce B, Halmi KA. Fat aversion in eating disorders. Appetite 1988; 10: 119-131.
49. Dreon DM, Frey-Hewitt B, Ellsworth N, Williams PT, Terry RB, Wood PD. Dietary fat: carbohydrate ratio and obesity in middle-aged men. Am J Clin Nutr 1988; 47: 995-1000.